NCT05105100 2026-04-06
Peripheral T Cell Determinants of Response and Resistance to Pembrolizumab in Melanoma
University of California, San Francisco
Completed
Clinical Trials
3 trialsNCT01445327 2022-02-01
Predictors of Tumor Response and of Radiation Therapy Side Effects in Patients With Gastrointestinal Cancers
National Institutes of Health Clinical Center (CC)
Terminated
NCT01345513 2020-03-23
Feasibility Clinical Study of Targeted and Genome-Wide Sequencing
University Health Network, Toronto
Completed